HSL Mobile App
Aspira Pathlab & Diagnostics Ltd
25 May 2026 12:00 AM
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.69 crore in the March 2026 quarter,
Net loss of Aspira Pathlab & Diagnostics reported to Rs 0.69 crore in the quarter ended March 2026 as against net profit of Rs 0.72 crore during the previous quarter ended March 2025. Sales rose 12.80% to Rs 6.52 crore in the quarter ended March 2026 as against Rs 5.78 crore during the previous quarter ended March 2025.For the full year,net profit declined 97.58% to Rs 0.05 crore in the year ended March 2026 as against Rs 2.07 crore during the previous year ended March 2025. Sales rose 13.55% to Rs 24.98 crore in the year ended March 2026 as against Rs 22.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales6.525.78 13 24.9822.00 14 OPM %-5.0618.17 -5.8416.00 - PBDT-0.291.09 PL 1.593.56 -55 PBT-0.690.72 PL 0.052.07 -98 NP-0.690.72 PL 0.052.07 -98 Powered by Capital Market - Live News
Aspira Pathlab & Diagnostics Ltd
19 May 2026 12:00 AM
Aspira Pathlab & Diagnostics to announce Quarterly Result,
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 23 May 2026.
Aspira Pathlab & Diagnostics Ltd
11 Feb 2026 12:00 AM
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 1.56 crore in the December 2025 quarter,
Net loss of Aspira Pathlab & Diagnostics reported to Rs 1.56 crore in the quarter ended December 2025 as against net profit of Rs 0.38 crore during the previous quarter ended December 2024. Sales declined 5.36% to Rs 5.12 crore in the quarter ended December 2025 as against Rs 5.41 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales5.125.41 -5 OPM %-23.6314.23 - PBDT-1.180.77 PL PBT-1.560.38 PL NP-1.560.38 PL Powered by Capital Market - Live News
Aspira Pathlab & Diagnostics Ltd
05 Feb 2026 12:00 AM
Aspira Pathlab & Diagnostics to declare Quarterly Results,
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live News
Aspira Pathlab & Diagnostics Ltd
13 Nov 2025 12:00 AM
Aspira Pathlab & Diagnostics standalone net profit rises 85.86% in the September 2025 quarter,
Net profit of Aspira Pathlab & Diagnostics rose 85.86% to Rs 1.84 crore in the quarter ended September 2025 as against Rs 0.99 crore during the previous quarter ended September 2024. Sales rose 30.91% to Rs 8.09 crore in the quarter ended September 2025 as against Rs 6.18 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales8.096.18 31 OPM %27.1921.84 - PBDT2.241.35 66 PBT1.840.99 86 NP1.840.99 86 Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter
